Protein kinase C-θ promotes Th17 differentiation via upregulation of Stat3

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 5887-5897

  Kwon, Myung Ja ^a   Ma, Jian ^a   Ding, Yan ^a   Wang, Ruiqing ^a   Sun, Zuoming ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C THETA; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; UP-REGULATION;

EID: 84862622067     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102941     Document Type: Article

References (52)

1. Kidd, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223-246. (Pubitemid 37099886)
2. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748. (Pubitemid 36227625)
3. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. (Pubitemid 40189432)
4. Ouyang, W., J. K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467. (Pubitemid 351471762)
5. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G. X. Zhang, B. N. Dittel, and A. Rostami. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
6. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
7. Haak, S., A. L. Croxford, K. Kreymborg, F. L. Heppner, S. Pouly, B. Becher, and A. Waisman. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119: 61-69.
8. Lubberts, E., M. I. Koenders, B. Oppers-Walgreen, L. van den Bersselaar, C. J. Coenen-de Roo, L. A. Joosten, and W. B. van den Berg. 2004. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50: 650-659. (Pubitemid 38198849)
9. Zhang, Z., M. Zheng, J. Bindas, P. Schwarzenberger, and J. K. Kolls. 2006. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 12: 382-388.
10. Matusevicius, D., P. Kivisäkk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5: 101-104. (Pubitemid 29186827)
11. Kirkham, B. W., M. N. Lassere, J. P. Edmonds, K. M. Juhasz, P. A. Bird, C. S. Lee, R. Shnier, and I. J. Portek. 2006. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 54: 1122-1131. (Pubitemid 43672925)
12. Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Pagé, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108: 430-438. (Pubitemid 32881066)
13. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463. (Pubitemid 44871953)
14. Krueger, G. G., R. G. Langley, C. Leonardi, N. Yeilding, C. Guzzo, Y. Wang, L. T. Dooley, and M. Lebwohl; CNTO 1275 Psoriasis Study Group. 2007. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356: 580-592. (Pubitemid 46220818)
15. Stockinger, B., M. Veldhoen, and B. Martin. 2007. Th17 T cells: linking innate and adaptive immunity. Semin. Immunol. 19: 353-361. (Pubitemid 351274048)
16. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
17. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641-649. (Pubitemid 351714729)
18. Rodig, S. J., M. A. Meraz, J. M. White, P. A. Lampe, J. K. Riley, C. D. Arthur, K. L. King, K. C. Sheehan, L. Yin, D. Pennica, et al. 1998. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93: 373-383. (Pubitemid 28232082)
19. Heinrich, P. C., I. Behrmann, G. Müller-Newen, F. Schaper, and L. Graeve. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334: 297-314. (Pubitemid 28448572)
20. Yang, X. O., A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282: 9358-9363. (Pubitemid 47104613)
21. Harris, T. J., J. F. Grosso, H. R. Yen, H. Xin, M. Kortylewski, E. Albesiano, E. L. Hipkiss, D. Getnet, M. V. Goldberg, C. H. Maris, et al. 2007. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17- dependent autoimmunity. J. Immunol. 179: 4313-4317.
22. Chen, Z., A. Laurence, Y. Kanno, M. Pacher-Zavisin, B. M. Zhu, C. Tato, A. Yoshimura, L. Hennighausen, and J. J. O'Shea. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103: 8137-8142. (Pubitemid 43801065)
23. Manicassamy, S., S. Gupta, Z. Huang, and Z. Sun. 2006. Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL. J. Immunol. 176: 6709-6716. (Pubitemid 43787854)
24. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404: 402-407. (Pubitemid 30164343)
25. Manicassamy, S., S. Gupta, Z. Huang, J. D. Molkentin, W. Shang, and Z. Sun. 2008. Requirement of calcineurin a beta for the survival of naive T cells. J. Immunol. 180: 106-112.
26. Manicassamy, S., S. Gupta, and Z. Sun. 2006. Selective function of PKC-theta in T cells. Cell. Mol. Immunol. 3: 263-270.
27. Manicassamy, S., M. Sadim, R. D. Ye, and Z. Sun. 2006. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells. J. Mol. Biol. 355: 347-359. (Pubitemid 41785743)
28. Manicassamy, S., and Z. Sun. 2007. The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis. J. Immunol. 178: 312-319. (Pubitemid 46033614)
29. Manicassamy, S., D. Yin, Z. Zhang, L. L. Molinero, M. L. Alegre, and Z. Sun. 2008. A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection. J. Immunol. 181: 513-520.
30. Altman, A., S. Kaminski, V. Busuttil, N. Droin, J. Hu, Y. Tadevosyan, R. A. Hipskind, and M. Villalba. 2004. Positive feedback regulation of PLCgamma1/Ca(2+) signaling by PKCtheta in restimulated T cells via a Tec kinase-dependent pathway. Eur. J. Immunol. 34: 2001-2011. (Pubitemid 39256081)
31. Pfeifhofer, C., K. Kofler, T. Gruber, N. G. Tabrizi, C. Lutz, K. Maly, M. Leitges, and G. Baier. 2003. Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197: 1525-1535. (Pubitemid 36682549)
32. Salek-Ardakani, S., T. So, B. S. Halteman, A. Altman, and M. Croft. 2005. Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis. J. Immunol. 175: 7635-7641. (Pubitemid 41713463)
33. Huang, Z., H. Xie, R. Wang, and Z. Sun. 2007. Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity. Expert Opin. Ther. Targets 11: 737-743. (Pubitemid 46901394)
34. Tan, S. L., J. Zhao, C. Bi, X. C. Chen, D. L. Hepburn, J. Wang, J. D. Sedgwick, S. R. Chintalacharuvu, and S. Na. 2006. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J. Immunol. 176: 2872-2879.
35. Huang, Z., H. Xie, V. Ioannidis, W. Held, H. Clevers, M. S. Sadim, and Z. Sun. 2006. Transcriptional regulation of CD4 gene expression by T cell factor-1/beta-catenin pathway. J. Immunol. 176: 4880-4887.
36. Veldhoen, M., K. Hirota, J. Christensen, A. O'Garra, and B. Stockinger. 2009. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206: 43-49.
37. Kwon, M. J., R. Wang, J. Ma, and Z. Sun. 2010. PKC-u is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection. Endocr. Metab. Immune Disord. Drug Targets 10: 367-372.
38. Vettese-Dadey, M., P. A. Grant, T. R. Hebbes, C. Crane-Robinson, C. D. Allis, and J. L. Workman. 1996. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15: 2508-2518. (Pubitemid 26151190)
39. Ichiba, M., K. Nakajima, Y. Yamanaka, N. Kiuchi, and T. Hirano. 1998. Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein. J. Biol. Chem. 273: 6132-6138. (Pubitemid 28144693)
40. Narimatsu, M., H. Maeda, S. Itoh, T. Atsumi, T. Ohtani, K. Nishida, M. Itoh, D. Kamimura, S. J. Park, K. Mizuno, et al. 2001. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol. Cell. Biol. 21: 6615-6625. (Pubitemid 32927428)
41. Baier, G. 2003. The PKC gene module: molecular biosystematics to resolve its T cell functions. Immunol. Rev. 192: 64-79. (Pubitemid 36613324)
42. Liu, Y., C. Graham, A. Li, R. J. Fisher, and S. Shaw. 2002. Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-kappaB induction. Biochem. J. 361: 255-265. (Pubitemid 34174492)
43. Lee, K. Y., F. D'Acquisto, M. S. Hayden, J. H. Shim, and S. Ghosh. 2005. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 308: 114-118. (Pubitemid 40471010)
44. Barouch-Bentov, R., E. E. Lemmens, J. Hu, E. M. Janssen, N. M. Droin, J. Song, S. P. Schoenberger, and A. Altman. 2005. Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells. J. Immunol. 175: 5126-5134. (Pubitemid 41456396)
45. Marsland, B. J., T. J. Soos, G. Späth, D. R. Littman, and M. Kopf. 2004. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200: 181-189. (Pubitemid 38982177)
46. Salek-Ardakani, S., T. So, B. S. Halteman, A. Altman, and M. Croft. 2004. Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C theta. J. Immunol. 173: 6440-6447. (Pubitemid 39487805)
47. Goldrath, A. W., and M. J. Bevan. 1999. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 11: 183-190. (Pubitemid 29428811)
48. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274. (Pubitemid 24046689)
49. Bi, K., and A. Altman. 2001. Membrane lipid microdomains and the role of PKCtheta in T cell activation. Semin. Immunol. 13: 139-146. (Pubitemid 32382335)
50. Villalba, M., K. Bi, J. Hu, Y. Altman, P. Bushway, E. Reits, J. Neefjes, G. Baier, R. T. Abraham, and A. Altman. 2002. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 157: 253-263. (Pubitemid 34839822)
51. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell 76: 253-262. (Pubitemid 24046688)
52. Taga, T., and T. Kishimoto. 1997. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15: 797-819. (Pubitemid 27169299)